DUBLIN and CHICAGO, Sept. 19, 2025 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM) (Iterum), a company focused on delivering next generation… DUBLIN and CHICAGO, Sept. 19, 2025 (...
DUBLIN and CHICAGO, Sept. 19, 2025 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM) (Iterum), a company focused on delivering next generation… DUBLIN and CHICAGO, Sept. 19, 2025 (...
